CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 48 filers reported holding CHEMBIO DIAGNOSTICS INC in Q3 2021. The put-call ratio across all filers is 2.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $123,575 | +202482.0% | 279,456 | 0.0% | 0.00% | – |
| Q4 2022 | $61 | -99.9% | 279,456 | -0.2% | 0.00% | – |
| Q3 2022 | $101,000 | -44.5% | 280,112 | 0.0% | 0.00% | – |
| Q2 2022 | $182,000 | -19.1% | 280,112 | +2.1% | 0.00% | – |
| Q1 2022 | $225,000 | -27.9% | 274,418 | -0.0% | 0.00% | – |
| Q4 2021 | $312,000 | -38.5% | 274,422 | +35.1% | 0.00% | – |
| Q3 2021 | $507,000 | +18.2% | 203,070 | +40.4% | 0.00% | – |
| Q2 2021 | $429,000 | -59.3% | 144,622 | -51.9% | 0.00% | – |
| Q1 2021 | $1,055,000 | -16.1% | 300,746 | +13.5% | 0.00% | – |
| Q4 2020 | $1,258,000 | +8.0% | 265,010 | +10.5% | 0.00% | – |
| Q3 2020 | $1,165,000 | +50.1% | 239,900 | +0.4% | 0.00% | – |
| Q2 2020 | $776,000 | +28.1% | 239,025 | +101.7% | 0.00% | – |
| Q1 2020 | $606,000 | -38.8% | 118,499 | -45.5% | 0.00% | – |
| Q4 2019 | $990,000 | +48.9% | 217,430 | +100.0% | 0.00% | – |
| Q3 2019 | $665,000 | +0.5% | 108,715 | 0.0% | 0.00% | – |
| Q2 2019 | $662,000 | +45.8% | 108,715 | +32.7% | 0.00% | – |
| Q1 2019 | $454,000 | -48.8% | 81,947 | -47.7% | 0.00% | – |
| Q4 2018 | $886,000 | +62.9% | 156,636 | +202.0% | 0.00% | – |
| Q3 2018 | $544,000 | -5.4% | 51,859 | 0.0% | 0.00% | – |
| Q2 2018 | $575,000 | +45.6% | 51,859 | +4.8% | 0.00% | – |
| Q1 2018 | $395,000 | -2.5% | 49,468 | 0.0% | 0.00% | – |
| Q4 2017 | $405,000 | +32.4% | 49,468 | 0.0% | 0.00% | – |
| Q3 2017 | $306,000 | +2.3% | 49,468 | 0.0% | 0.00% | – |
| Q2 2017 | $299,000 | +14.1% | 49,468 | 0.0% | 0.00% | – |
| Q1 2017 | $262,000 | -16.3% | 49,468 | +7.1% | 0.00% | – |
| Q4 2016 | $313,000 | -7.9% | 46,174 | 0.0% | 0.00% | – |
| Q3 2016 | $340,000 | +98.8% | 46,174 | +120.1% | 0.00% | – |
| Q2 2016 | $171,000 | +76.3% | 20,979 | +28.5% | 0.00% | – |
| Q1 2016 | $97,000 | +11.5% | 16,328 | 0.0% | 0.00% | – |
| Q4 2015 | $87,000 | +33.8% | 16,328 | 0.0% | 0.00% | – |
| Q3 2015 | $65,000 | -18.8% | 16,328 | 0.0% | 0.00% | – |
| Q2 2015 | $80,000 | +25.0% | 16,328 | 0.0% | 0.00% | – |
| Q1 2015 | $64,000 | +1.6% | 16,328 | 0.0% | 0.00% | – |
| Q4 2014 | $63,000 | – | 16,328 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 344,060 | $1,634,000 | 1.26% |
| Union Square Park Capital Management, LLC | 400,000 | $1,900,000 | 0.76% |
| P.A.W. CAPITAL CORP | 100,000 | $475,000 | 0.42% |
| PRECEPT MANAGEMENT LLC | 150,000 | $713,000 | 0.29% |
| Newbridge Financial Services Group, Inc. | 73,500 | $349,000 | 0.29% |
| SANDERS MORRIS HARRIS LLC | 183,584 | $990,000 | 0.22% |
| FRIESS ASSOCIATES LLC | 555,000 | $2,636,000 | 0.19% |
| PERRITT CAPITAL MANAGEMENT INC | 30,651 | $146,000 | 0.09% |
| Ikarian Capital, LLC | 219,109 | $1,041,000 | 0.05% |
| SEGALL BRYANT & HAMILL, LLC | 705,823 | $3,352,000 | 0.04% |